Kurs
-2,53%
Kurs
-2,53%
Kalender
| Est. tid* | ||
| 2025-10-31 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-11 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-30 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-28 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2025-04-25 | - | Årsstämma |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-11-01 | - | Kvartalsrapport 2024-Q3 |
| 2024-09-09 | - | X-dag ordinarie utdelning AKBM 45.00 NOK |
| 2024-09-03 | - | Extra Bolagsstämma 2024 |
| 2024-07-12 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-17 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2024-04-16 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-01 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2023-04-20 | - | Årsstämma |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-01 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-14 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-14 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-15 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
| 2021-03-12 | - | Årsstämma |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-15 | - | Kvartalsrapport 2020-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2023-02-17 17:22:58
Matts Johansen, CEO of Aker BioMarine ASA has through KMMN Invest II AS, a
company controlled by Mr. Johansen, today purchased 6,965 shares in Aker
BioMarine ASA at an average price of NOK 39.94 per share. Following the
transaction, Mr. Johansen, directly and indirectly, controls 1,079,348 shares in
Aker BioMarine ASA.
Please see attached primary insider notification form pursuant to the
requirements of the Market Abuse Regulation ("MAR").
This information is subject to the disclosure requirements pursuant to MAR
Article 19 and Section 5-12 of the Norwegian Securities Trading Act.